Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-12 Vounatsos Michel Chief Executive Officer Grant or award · Restricted Stock Unit +36,320 36,320
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −598 $316.63 $189K 6,553.38
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise +2,012 8,565.38
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −718 $316.63 $227K 7,847.38
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Grant or award · Restricted Stock Unit +3,315 3,315
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Grant or award · Restricted Stock Unit +8,290 8,290
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −2,012 4,816
2018-02-12 Sandrock Alfred EVP, Chief Medical Officer Other disposition · Restricted Stock Unit −1,398 3,418
2018-01-09 PANGIA ROBERT W Director Option exercise +5,832 $57.83 $337K 23,539
2018-01-09 PANGIA ROBERT W Director Sale −5,832 $329.65 $1.9M 17,707
2018-01-09 PANGIA ROBERT W Director Option exercise · Stock Option (Right to Buy) −5,832 0
2018-01-02 CAPELLO JEFFREY D EVP & Chief Financial Officer Grant or award · Restricted Stock Unit +8,980 8,980
2018-01-02 CAPELLO JEFFREY D EVP & Chief Financial Officer Grant or award · Performance Stock Unit +5,390 5,390
2017-12-29 Vounatsos Michel Chief Executive Officer Purchase +780 $320.55 $250K 4,879.46
2017-12-01 Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov Grant or award · Restricted Stock Unit +3,510 3,510
2017-12-01 Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov Grant or award +2,350 2,350
2017-12-01 Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov Grant or award · Restricted Stock Unit +1,755 1,755
2017-12-01 COVINO GREGORY F VP, Chief Accounting Officer Shares withheld for taxes −54 $319.35 $17K 4,542.36
2017-12-01 COVINO GREGORY F VP, Chief Accounting Officer Shares withheld for taxes −103 $319.35 $33K 4,439.36
2017-11-29 SHERWIN STEPHEN A Director Gift −250 5,734

Page 60 of 61 · 1,204 trades